TY - JOUR
T1 - Comparative study on the combined effects of bunazosin and nipradilol or timolol on intraocular pressure in normotensive rabbits
AU - Orihashi, Masahiro
AU - Shima, Yuichiro
AU - Tsuneki, Hiroshi
AU - Kimura, Ikuko
PY - 2005/11
Y1 - 2005/11
N2 - Purpose: To compare the ocular hypotensive effect of nipradilol and timolol in combination with bunazosin in rabbits. Methods: The intraocular pressure (IOP) in normal rabbits was measured using an applanation pneumatonograph. Nipradilol, timolol, and bunazosin were instilled, individually or in combination, into the inferior conjunctival sac. Results: Nipradilol (0.25%), timolol (0.5%), and bunazosin (0.01%) individually lowered IOP. The IOP-lowering effects of both nipradilol and timolol were significantly enhanced by the combined application of bunazosin (0.01%). In the presence of 5% timolol or 0.1% bunazosin, IOP was further lowered by the addition of nipradilol. The IOP-lowering effect of nipradilol was partly inhibited by pretreatment with c-PTIO (10 mM), a nitric oxide (NO)-trapping agent. Conclusions: The present study demonstrated that the IOP-lowering effects of nipradilol are due to β- and α1-blocking and NO-donating actions, and bunazosin has an additive effect on the IOP-lowering effect of nipradilol or timolol.
AB - Purpose: To compare the ocular hypotensive effect of nipradilol and timolol in combination with bunazosin in rabbits. Methods: The intraocular pressure (IOP) in normal rabbits was measured using an applanation pneumatonograph. Nipradilol, timolol, and bunazosin were instilled, individually or in combination, into the inferior conjunctival sac. Results: Nipradilol (0.25%), timolol (0.5%), and bunazosin (0.01%) individually lowered IOP. The IOP-lowering effects of both nipradilol and timolol were significantly enhanced by the combined application of bunazosin (0.01%). In the presence of 5% timolol or 0.1% bunazosin, IOP was further lowered by the addition of nipradilol. The IOP-lowering effect of nipradilol was partly inhibited by pretreatment with c-PTIO (10 mM), a nitric oxide (NO)-trapping agent. Conclusions: The present study demonstrated that the IOP-lowering effects of nipradilol are due to β- and α1-blocking and NO-donating actions, and bunazosin has an additive effect on the IOP-lowering effect of nipradilol or timolol.
KW - Bunazosin
KW - Intraocular pressure
KW - Nipradilol
KW - Nitric oxide
KW - β- and α1-blocking activity
UR - http://www.scopus.com/inward/record.url?scp=29244442241&partnerID=8YFLogxK
U2 - 10.1007/s10384-004-0232-2
DO - 10.1007/s10384-004-0232-2
M3 - 学術論文
C2 - 16365801
AN - SCOPUS:29244442241
SN - 0021-5155
VL - 49
SP - 523
EP - 526
JO - Japanese Journal of Ophthalmology
JF - Japanese Journal of Ophthalmology
IS - 6
ER -